Dodgers activate Evan Phillips 13 months after Tommy John surgery

Los Angeles Dodgers reliever Evan Phillips was activated from the 60‑day injured list on Tuesday, ending a 13‑month recovery from Tommy John surgery and marking the first major bullpen reinforcement since the season began.

Core developments

Phillips, who underwent ulnar collateral ligament reconstruction in June 2025, returned to the active roster after completing a full rehabilitation program. The move was confirmed by the club’s official roster move announcement, which noted his activation and the corresponding designation of catcher Ben Rortvedt for assignment.

In addition to the roster change, the Dodgers announced a new contract with Phillips, securing his services through the 2027 season. The agreement, reported by MLB Trade Rumors, reflects the organization’s confidence that Phillips can contribute to a bullpen that has been depleted by injuries to key arms.

Phillips’ return comes after a stint on the 60‑day IL that began in August 2025. During his rehab, he logged multiple bullpen sessions and a series of simulated games, a process described by MLB.com as “pen reinforcements as Phillips returns from Tommy John.” The club’s medical staff cleared him after a series of progressive throws that met the organization’s velocity and command benchmarks.

True Blue LA highlighted that Phillips’ first major‑league appearance since the surgery is expected within the next week, noting that the Dodgers will likely ease him into low‑leverage situations before expanding his role.

ESPN emphasized the length of the recovery, stating that Phillips is back 13 months after the procedure, a timeline that aligns with the typical return window for pitchers who undergo the surgery.

Why it matters

The Dodgers entered the 2026 season with a bullpen that ranked near the bottom of the league in inherited runners scored, a metric that has long been a barometer of relief effectiveness. Injuries to left‑handed options such as Blake Treinen and right‑handed specialists like Blake Treinen (note: same name appears in multiple reports) forced the club to rely heavily on unproven arms.

Phillips, a right‑hander who posted a 3.68 ERA across 76 appearances in 2024, offers a proven middle‑relief profile. His ability to throw a mid‑90s fastball and a sharp slider makes him a versatile piece capable of handling both high‑leverage innings and bridge work between the starter and the closer. By re‑signing him, the Dodgers not only retain a known quantity but also send a signal to free‑agent relievers that the club is actively addressing its bullpen depth.

The timing also dovetails with the Dodgers’ broader roster strategy. With the trade deadline approaching, the front office has been gauging whether to pursue additional arms via trade or to lean on internal options. Phillips’ activation reduces the urgency to acquire a veteran reliever at the market price, potentially freeing salary‑cap space for other needs, such as a starting rotation depth piece.

Differing viewpoints and reactions

Club insiders, as reported by MLB.com, praised the medical staff’s diligence, noting that “the Dodgers have been methodical in getting Phillips back” and that his health status will be monitored closely during the first few outings.

Conversely, some analysts expressed caution. The New York Post pointed out that while the activation is a positive step, the Dodgers’ bullpen has “still struggled to find consistency,” and that Phillips’ performance post‑surgery remains an unknown variable. The outlet suggested that the team’s success will hinge on how quickly Phillips can regain his pre‑injury command.

Fans on social media, referenced in the True Blue LA piece, expressed optimism, with many highlighting Phillips’ previous clutch appearances in the postseason. However, a minority warned that “returning from Tommy John is never a guarantee of the same effectiveness,” echoing a common sentiment among baseball observers.

What’s next

Phillips is slated to make his first appearance in a low‑pressure situation, likely against a mid‑range opponent, to test his stamina and command. The Dodgers plan to track his pitch count closely, aiming for a gradual build‑up to a full workload by the end of the month.

Should Phillips demonstrate durability, the club may consider expanding his role, potentially positioning him as a set‑up man for closer Blake Treinen. The bullpen’s performance in the next two weeks will be a key factor in determining whether the Dodgers will pursue additional relievers at the trade deadline.

Meanwhile, the designation of Ben Rortvedt opens a roster spot that could be used for a utility infielder or a fresh arm, depending on how the season’s injury landscape evolves. The Dodgers’ front office, led by President of Baseball Operations Andrew Friedman, will likely continue to evaluate internal options while keeping an eye on the market for any high‑impact relievers that become available.

In summary, Evan Phillips’ activation marks a pivotal moment for a bullpen that has been under pressure all season. His health, performance, and the club’s strategic decisions in the coming weeks will shape the Dodgers’ postseason aspirations.